CDMO Investors Have the Opportunity to Join Investigation of Avid Bioservices, Inc. with the Schall Law Firm

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in Avid Bioservices, Inc. (“Avid” or “the Company”) (NASDAQ: CDMO) for potential breaches of fiduciary duty on the part of its directors and management.

The investigation focuses on determining if the Avid board breached its fiduciary duties to shareholders. The Company announced that it will be acquired by GHO Capital Partners and Ampersand Capital Partners in a $1.1 billion all-cash transaction.

If you are a shareholder, click here to participate.

We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at [e-mail].

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

View source version on businesswire.com: https://www.businesswire.com/news/home/20241202005942/en/

The Avid Bioservices Stock at the time of publication of the news with a fall of -0,85 % to 11,70EUR on Tradegate stock exchange (29. November 2024, 22:26 Uhr).